Skip to content

Share Buybacks at other companies

AngioDynamics logo
AngioDynamicsANGO
$0
United Therapeutics logo
United TherapeuticsUTHR
$1.5B
Organogenesis Holdings Inc. logo
Organogenesis Holdings Inc.ORGO
$6.37M
Viemed Healthcare, Inc. logo
Viemed Healthcare, Inc.VMD
$1.44M
ResMed logo
ResMedRMD
$175.01M+133%
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$75.3M+22.8%
Gross profit$57.6M+27.1%
Operating income-$1.5M+66.2%
Net income-$1.8M+40.7%
EPS (diluted)-$0.08+38.5%

Balance sheet

See full
Cash & equivalents$75.0M-10.3%
Total debt$15.2M-62.7%
Total equity$217.9M+5.9%
Total assets$272.1M-2.9%

Cash flow

See full
Operating cash flow-$339.0K-181%
CapEx$821.0K+117%
Free cash flow-$1.2M-3,153%

Valuation

See full
Market cap$631.58M+172%
Enterprise value$571.76M+203%
P/E31.1×+16.8×
P/S1.8×+1.0×

Profitability

See full
Gross margin76.4%+1.8pp
Operating margin9.4%+2.4pp
Net margin5.9%+0.4pp
FCF margin11.4%-1.5pp

Returns & leverage

See full
Return on equity9.6%+1.5pp
Debt / equity0.1×-0.1×
Current ratio4.2×-0.3×

Where this comes from

Reported directly by Tactile Systems Technology in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: Tactile Systems Technology’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Tactile Systems Technology's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Tactile Systems Technology's share buybacks?
Tactile Systems Technology (TCMD) reported share buybacks of $1.07M in Q1 2026.
How has Tactile Systems Technology's share buybacks changed year-over-year?
Tactile Systems Technology's share buybacks decreased by 89.3% year-over-year, from $10.02M to $1.07M.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.